cannabis indica

Canabinol (CBN)

termo de indexação original: Cannabinol (CBN)

O que é Canabinol (CBN)

O canabinol, ou CBN, tem uma origem incomum: a planta não o produz. Ele se forma quando o THC se oxida — por exposição ao ar, à luz e ao tempo. Concentrações altas de CBN são, na prática, um indicador de material envelhecido ou mal armazenado.

Historicamente é o primeiro canabinoide a ter a estrutura elucidada, nos anos 1930, décadas antes do THC. Por isso a pesquisa inicial sobre cannabis, no começo do século 20, atribuiu a ele efeitos que depois se mostraram do THC.

O CBN liga-se aos receptores CB1 e CB2, mas com afinidade bem menor que o THC, e é descrito como fracamente psicoativo. A associação popular entre CBN e sono é anterior à evidência que a sustente — e é uma das razões pelas quais o composto voltou a ser estudado.

No acervo

O acervo do Cannabis Indica reúne 125 estudos científicos que tocam o composto Canabinol (CBN), publicados entre 1896 e 2024. Pela leitura automatizada, 70 (56%) foram classificados como favoráveis, 37 (30%) como inconclusivos e 18 (14%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (45 estudos), seguido de estudo laboratorial (41). As condições mais associadas são Câncer, Dor e Inflamação.

Estudos indexados
125
Período coberto
1896–2024
Favoráveis
70 · 56%
Inconclusivos
37 · 30%
Desfavoráveis
18 · 14%
Termo original
Cannabinol (CBN)

O acervo em números

Tipo de estudo

Metanálise45
Estudo Laboratorial41
Estudo em Animais17
Ensaio Clínico11
Ensaio Clínico Duplo-Cego9
Metanálise Clínica2

Direção do resultado

Favorável70
Inconclusivo37
Desfavorável18

Por década

1890s1
1940s2
1970s5
1980s3
1990s1
2000s8
2010s25
2020s80

125 estudos

Filtrar e buscar no acervo →
  1. 2024

    Anticancer effect of minor phytocannabinoids in preclinical models of multiple myeloma

    FavorávelEstudo em AnimaisCâncer — MielomaCanabigerol (CBG)Canabicromeno (CBC)+1
  2. 2024

    Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

    InconclusivoMetanáliseDorDor — AgudaAnandamida (AEA)Tetraidrocanabinol (THC)+7
  3. 2024

    The inhibitory effects of cannabinoids, the active constituents of Cannabis sativa L. on human and rabbit platelet aggregation

    InconclusivoEstudo LaboratorialDistúrbios de CoagulaçãoTetraidrocanabinol (THC)Canabigerol (CBG)
  4. 2023

    A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality

    FavorávelEnsaio Clínico Duplo-CegoInsônia e Distúrbios do Sono
  5. 2023

    A Randomized, Double-Blind, Placebo-Controlled Decentralized Trial to Assess Sleep, Health Outcomes, and Overall Well-Being in Healthy Adults Reporting Disturbed Sleep, Taking a Melatonin-Free Supplement

  6. 2023

    Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

    FavorávelEstudo LaboratorialDorCâncerInflamaçãoTetraidrocanabinol (THC)THC Farmacêutico+25
  7. 2023

    Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

  8. 2023

    Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance

  9. 2023

    The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial

  10. 2022

    A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment

    FavorávelMetanáliseDorCâncerAnsiedadeAnandamida (AEA)Tetraidrocanabinol (THC)+25
  11. 2022

    Biological effects of cannabidiol on human cancer cells: Systematic review of the literature

  12. 2022

    Cannabinoids, Insomnia, and Other Sleep Disorders

    InconclusivoMetanáliseInsônia e Distúrbios do Sono
  13. 2022

    Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors

    FavorávelEstudo LaboratorialEstresse OxidativoDoenças Neurodegenerativas
  14. 2022

    Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma

    FavorávelEstudo em AnimaisGlaucoma
  15. 2022

    Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid

    FavorávelMetanáliseDorInflamaçãoDor — Crônica+6
  16. 2022

    Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

  17. 2022

    Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein

  18. 2022

    Cannabis Use and the Endocannabinoid System: A Clinical Perspective

  19. 2022

    Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

    FavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)Tetraidrocanabinol (THC)+28
  20. 2022

    Cutaneous Squamous Cell Carcinoma and Lichen Simplex Chronicus Successfully Treated with Topical Cannabinoid Oil: A Case Report and Summary of Cannabinoids in Dermatology

  21. 2022

    Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.)

  22. 2022

    Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study

  23. 2022

    Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis

    DesfavorávelMetanáliseCâncerCanabigerol (CBG)Canabicromeno (CBC)
  24. 2022

    Industrial Hemp ( Cannabis sativa L.) Inflorescences as Novel Food: The Effect of Different Agronomical Practices on Chemical Profile

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabicromeno (CBC)+3
  25. 2022

    Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabicromeno (CBC)+3
  26. 2022

    Is There a Place for Medicinal Cannabis in Treating Patients with Sleep Disorders? What We Know so Far

  27. 2022

    Marijuana-induced myocarditis in a 24-year-old man

  28. 2022

    Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules

    InconclusivoEstudo em AnimaisDorPalmitoiletanolamida (PEA)Ácido Tetraidrocanabinólico (THC-a)
  29. 2022

    Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives

  30. 2022

    Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway

  31. 2022

    Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

    FavorávelEnsaio ClínicoDorCâncerDor — CrônicaÁcido Canabidiólico (CBD-a)+7
  32. 2022

    Post-Harvest Operations to Generate High-Quality Medicinal Cannabis Products: A Systemic Review

    InconclusivoMetanáliseCanabigerol (CBG)Canabicromeno (CBC)+2
  33. 2022

    Profiling Cannabinoid Contents and Expression Levels of Corresponding Biosynthetic Genes in Commercial Cannabis (Cannabis sativa L.) Cultivars

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabigerol (CBG)+8
  34. 2022

    Regulating for Safety: Cannabidiol Dose in Food: A Review

    DesfavorávelMetanáliseCanabigerol (CBG)Canabicromeno (CBC)+5
  35. 2022

    Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations

  36. 2022

    Sex differences in medical cannabis-related adverse effects

  37. 2022

    Synaptic changes induced by cannabinoid drugs and cannabis use disorder

  38. 2022

    The effect of medical cannabis on cognitive functions: a systematic review

    DesfavorávelMetanálise ClínicaDorCâncerEfeitos Adversos da CannabisTHC:CBD FarmacêuticoCBD Farmacêutico+11
  39. 2022

    The Medicinal Natural Products of Cannabis sativa Linn.: A Review

  40. 2022

    Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users

    InconclusivoEnsaio Clínico Duplo-CegoTetraidrocanabivarina (THCV)Delta-8-THC
  41. 2021

    A Change in Blood Carbamazepine Levels Associated With Cannabis Use: Implications for Clinical Practice

  42. 2021

    Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation

    FavorávelEstudo LaboratorialEstresse OxidativoCanabigerol (CBG)Canabicromeno (CBC)
  43. 2021

    Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath

    FavorávelEnsaio Clínico Duplo-CegoCanabigerol (CBG)Tetraidrocanabivarina (THCV)+1
  44. 2021

    Brain imaging of cannabinoid type I (CB1 ) receptors in women with cannabis use disorder and male and female healthy controls

  45. 2021

    Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study

  46. 2021

    Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions

    DesfavorávelEstudo LaboratorialEfeitos Adversos da CannabisInsuficiência Hepática
  47. 2021

    Cannabinoid Quinones—A Review and Novel Observations

  48. 2021

    Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective

  49. 2021

    Cannabinol and Sleep: Separating Fact from Fiction

    InconclusivoMetanáliseInsônia e Distúrbios do Sono
  50. 2021

    Cannabis and Autoimmunity: Possible Mechanisms of Action

  51. 2021

    Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+17
  52. 2021

    CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action

    FavorávelEstudo LaboratorialEstresse OxidativoCanabigerol (CBG)Ácido Canabidiólico (CBD-a)+2
  53. 2021

    Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study

    FavorávelEnsaio ClínicoCanabigerol (CBG)Canabicromeno (CBC)+7
  54. 2021

    Development and Optimization of Supercritical Fluid Extraction Setup Leading to Quantification of 11 Cannabinoids Derived from Medicinal Cannabis

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabigerol (CBG)+7
  55. 2021

    Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms

    InconclusivoEstudo LaboratorialAnandamida (AEA)Tetraidrocanabinol (THC)+3
  56. 2021

    Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood

    DesfavorávelEstudo em AnimaisEfeitos Adversos da CannabisAnsiedadeDisfunção Cognitiva
  57. 2021

    Fast liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phytocannabinoids in oily based preparations

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Ácido Canabidiólico (CBD-a)+2
  58. 2021

    Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?

    InconclusivoEstudo LaboratorialCOVID-19Canabigerol (CBG)Ácido Tetraidrocanabinólico (THC-a)+1
  59. 2021

    Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Tetraidrocanabivarina (THCV)
  60. 2021

    Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses

    FavorávelMetanáliseCanabigerol (CBG)Canabicromeno (CBC)+3
  61. 2021

    Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids

  62. 2021

    Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study

    FavorávelEnsaio ClínicoEnxaqueca
  63. 2021

    Orally administered cannabidiol does not produce false-positive tests for Δ9 -tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisCanabigerol (CBG)
  64. 2021

    Quantitation of Δ8-THC, Δ9-THC, Cannabidiol, and Ten Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS/MS

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabicromeno (CBC)+3
  65. 2021

    Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS

    InconclusivoEstudo LaboratorialCanabinoide Sintético (não especificado)THC Farmacêutico+2
  66. 2021

    Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro

  67. 2021

    The antimicrobial effect behind Cannabis sativa

    FavorávelMetanáliseInfecções BacterianasAnandamida (AEA)Canabigerol (CBG)+5
  68. 2021

    The Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin, and 11-nor-9-carboxy-∆9-THC in Hair

    FavorávelEstudo LaboratorialTetraidrocanabivarina (THCV)
  69. 2020

    Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells

  70. 2020

    Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients

    FavorávelMetanáliseTDA e TDAH
  71. 2020

    Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — MamaTetraidrocanabinol (THC)Canabigerol (CBG)
  72. 2020

    Cannabinoids and Cannabinoid Receptors: The Story so Far

    InconclusivoMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+5
  73. 2020

    Cannabinol in the spotlight: Toxicometabolomic study and behavioral analysis of zebrafish embryos exposed to the unknown cannabinoid

  74. 2020

    Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish

    FavorávelEstudo em AnimaisEpilepsia
  75. 2020

    Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study

    FavorávelEnsaio ClínicoDorDor — CrônicaEsclerose MúltiplaTetraidrocanabinol (THC)+4
  76. 2020

    Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation

    FavorávelEstudo LaboratorialCáriesCanabigerol (CBG)Canabicromeno (CBC)+1
  77. 2020

    Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoDorDepressãoInsônia e Distúrbios do SonoCanabigerol (CBG)Canabicromeno (CBC)+3
  78. 2020

    It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets

    FavorávelMetanáliseTHC FarmacêuticoTHC:CBD Farmacêutico+4
  79. 2020

    The Influence of Hemp Extract in Combination with Ginger on the Metabolic Activity of Metastatic Cells and Microorganisms

  80. 2020

    Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath

    FavorávelEstudo LaboratorialTetraidrocanabivarina (THCV)
  81. 2019

    A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC

    FavorávelMetanáliseCâncerInflamaçãoDisfunção CognitivaCanabigerol (CBG)+5
  82. 2019

    Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain

    FavorávelEstudo em AnimaisFibromialgiaDistoniaDisfunção Temporomandibular (DTM)
  83. 2019

    Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease

    InconclusivoEstudo LaboratorialTosseBronquite
  84. 2019

    Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method

    InconclusivoEstudo LaboratorialGestação
  85. 2019

    Diverse TRPV1 responses to cannabinoids

    InconclusivoEstudo LaboratorialDorDor — CrônicaDor — Neuropatia PeriféricaCanabigerol (CBG)
  86. 2019

    Future Aspects for Cannabinoids in Breast Cancer Therapy

  87. 2019

    Inhalation of marijuana affects Drosophila heart function

    InconclusivoEstudo em AnimaisDoenças Cardiovasculares (DCV)Arritmias Cardíacas
  88. 2019

    Marijuana-derived cannabinoids inhibit uterine endometrial stromal cell decidualization and compromise trophoblast-endometrium cross-talk

    DesfavorávelEstudo LaboratorialGestação
  89. 2019

    Simultaneous Quantification of 13 Cannabinoids and Metabolites in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry in Adult Epilepsy Patients

    InconclusivoMetanáliseEpilepsiaTetraidrocanabinol (THC)Canabigerol (CBG)+5
  90. 2019

    The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications

    DesfavorávelEstudo LaboratorialEfeitos Adversos da Cannabis
  91. 2018

    Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.

    FavorávelEstudo em AnimaisEfeitos Adversos da Cannabis
  92. 2018

    Cannabinoids, the Heart of the Matter.

  93. 2018

    Standardized cannabis in multiple sclerosis: a case report.

    FavorávelMetanáliseEsclerose MúltiplaTetraidrocanabinol (THC)
  94. 2017

    Molecular Targets of the Phytocannabinoids-A Complex Picture

    InconclusivoMetanáliseTetraidrocanabinol (THC)Canabigerol (CBG)+3
  95. 2016

    Cannabinoids, Inflammation, and Fibrosis

  96. 2016

    Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake

    InconclusivoEnsaio Clínico Duplo-CegoCanabigerol (CBG)Tetraidrocanabivarina (THCV)
  97. 2014

    Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review

    InconclusivoMetanáliseTetraidrocanabinol (THC)Canabinoides Sintéticos AM-x+1
  98. 2014

    Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking

    DesfavorávelEnsaio ClínicoDependência — Cannabis
  99. 2014

    The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC–MS/MS

    DesfavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaEfeitos Adversos do MDMATHC:CBD Farmacêutico
  100. 2014

    The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study

    FavorávelEnsaio ClínicoDorDor — CrônicaDor — Neuropatia Periférica
  101. 2013

    Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile

  102. 2013

    Non-THC Cannabinoids Inhibit Prostate Carcinoma Growth In Vitro And In Vivo: Pro-apoptotic Effects And Underlying Mechanisms

    FavorávelEstudo em AnimaisCâncerCâncer — PróstataCanabigerol (CBG)Canabicromeno (CBC)+4
  103. 2012

    Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

  104. 2011

    Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

  105. 2010

    Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

    FavorávelEstudo em AnimaisDepressãoTetraidrocanabinol (THC)Canabigerol (CBG)+1
  106. 2008

    Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study.

    FavorávelEstudo LaboratorialInfecção por EstafilococosTetraidrocanabinol (THC)Canabigerol (CBG)+1
  107. 2007

    Anticoagulant effects of a Cannabis extract in an obese rat model

    FavorávelEstudo em AnimaisDistúrbios de Coagulação
  108. 2006

    Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.

  109. 2005

    Cannabinol Delays Symptom Onset In SOD1 (G93A) Transgenic Mice Without Affecting Survival

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasEsclerose Lateral Amiotrófica (ELA)
  110. 2005

    Therapeutic opportunities through modulation of the endocannabinoid system

  111. 2004

    Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol

    FavorávelEstudo LaboratorialDoenças de PeleDelta-8-THC
  112. 2004

    Synthesis and antitumor activity of quinonoid derivatives of cannabinoids

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoDelta-8-THC
  113. 2002

    Δ9-Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor-Independent Mechanism

    FavorávelEstudo LaboratorialDorTetraidrocanabinol (THC)Capsaicina (CAPS)
  114. 1995

    Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors

    InconclusivoEstudo LaboratorialAnandamida (AEA)Tetraidrocanabinol (THC)+3
  115. 1987

    Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.

    FavorávelEstudo em AnimaisMiastenia Gravis
  116. 1984

    Early cannabinoid exposure influences neuroendocrine and reproductive functions in male mice: I. Prenatal exposure

    DesfavorávelEstudo em AnimaisEfeitos Adversos da CannabisGestaçãoInfertilidade Masculina+1
  117. 1984

    Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects

    DesfavorávelEstudo em AnimaisSíndrome MetabólicaGestaçãoAlterações Cerebrais Neonatais+2
  118. 1976

    Antitussive activity of some naturally occurring cannabinoids in anesthetized cats.

    FavorávelEstudo em AnimaisTosseTetraidrocanabinol (THC)
  119. 1976

    Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns

    FavorávelEnsaio ClínicoInsônia e Distúrbios do Sono
  120. 1975

    Antineoplastic Activity Of Cannabinoids

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoCâncer — LeucemiaTetraidrocanabinol (THC)
  121. 1973

    Marijuana : medical papers, 1839-1972

    InconclusivoMetanáliseDorEfeitos Adversos da CannabisDependência — Cannabis+4
  122. 1970

    Chemical basis of hashish activity

  123. 1949

    Anti-epileptic Action of Marijuana-Active Subtances

  124. 1945

    Marihuana activity of cannabinol

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  125. 1896

    Chemistry, Pharmacy and Other Allied Subjects-Indian Hemp Constituents-Guttapercha from Leaves-Antipyrin as a Poison-Anti-Choleraic Serum-Two Kinds of X Rays-Oxygen Gas as a Restorative-Pepsin Digestion-Aseptic Surgical Catgut-Mercuric Cyanide in Ophthalmic Practice-Endosine in Intestinal Catarrh-Quinosol: A New Antiseptic-Malakin in Acute Rheumatism - Electric Treatment of Diabetes-Mustard Oil as a Poison in Trinidad-Tuberculosis in Goats-The X Rays in Dentistry-The Action of the Röntgen Rays on Certain Microbes-Diagnostic Value of the X Rays-"Photographing Thought"

    InconclusivoMetanáliseEfeitos Adversos da Cannabis

Continue por aqui

Perguntas frequentes

Quantos estudos sobre canabinol (cbn) estão indexados no acervo?
São 125 estudos, publicados entre 1896 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 45 · Estudo Laboratorial: 41 · Estudo em Animais: 17 · Ensaio Clínico: 11 · Ensaio Clínico Duplo-Cego: 9 · Metanálise Clínica: 2. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 70 favoráveis, 37 inconclusivos e 18 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Canabinol (CBN) — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/canabinoide/canabinol-cbn/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Canabinol (CBN) — estudos científicos sobre cannabis. https://cannabisindica.com.br/canabinoide/canabinol-cbn/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.